The Canadian unit of American tech giant IBM (NYSE:) has partnered with pharmaceutical company Boehringer Ingelheim to deploy blockchain in clinical recordkeeping, according to a press release published on Feb. 12.
The cooperation between the two companies aims to test whether the integration of blockchain technology with clinical recordkeeping provides the proper level of data integrity, transparency, and patient safety, in addition to reducing costs and automating processes.
Continue Reading on CoinTelegraph
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.